Doxazosin Tablet
Product Images NDC 16571-168

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 16571-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazocin-1mg (Doxazocin 1mg)

Doxazosin Tablets USP 1 mg oral tablets package label from Rising Pharma Holdings, Inc. The label states 100 tablets per bottle, with prescription use only. It includes storage instructions and mentions the active ingredient as doxazosin mesylate USP equivalent to 1 mg doxazosin. The label also shows manufacturing details and space for batch printing, with barcodes on the right side.*

FDA Label Image

Doxazocin-2mg (Doxazocin 2mg)

Doxazosin Tablets USP 2 mg oral tablets label from Rising Pharma Holdings, Inc. The label states the product contains 100 tablets, is prescription-only, and provides storage instructions. It includes manufacturer information, barcode, and batch printing area. Tablets contain doxazosin mesylate equivalent to 2 mg doxazosin.*

FDA Label Image

Doxazocin-4mg (Doxazocin 4mg)

Doxazosin Tablets USP 4 mg oral tablets in a 100-tablet package from Rising Pharma Holdings, Inc. The label includes dosage information, storage instructions at 25°C (77°F), a warning to keep out of reach of children, and indicates the product is Rx only. The label also shows the NDC number 16571-167-01 and barcode, with the product made in India.*

FDA Label Image

Doxazocin-8mg (Doxazocin 8mg)

Doxazosin Tablets USP 8 mg oral tablets, in a package containing 100 tablets labeled Rx only. The label shows the manufacturer as Rising Pharma Holdings, Inc., with storage instructions and dosage information. The product is made in India and includes barcodes and lot information placeholders.*

FDA Label Image

Doxazocin-structure.jpg (Doxazocin Structure)

Chemical structure of doxazosin, showing its molecular framework including methoxy groups, a piperazine ring, and a benzodioxane moiety.*

FDA Label Image

Figure-1 (Figure 1)

Two line graphs showing clinical trial results for Doxazosin tablets versus placebo over 14 weeks. The first graph plots mean change in total symptom score from baseline, showing greater symptom score reduction with Doxazosin. The second graph shows mean increase in maximum urinary flow rate, with Doxazosin demonstrating higher flow rate improvements compared to placebo.*

FDA Label Image

Table-3 (Table 3)

A figure showing a bar graph comparing maximum flow rate (mL/sec) and symptom score changes across placebo and Doxazosin tablets at 4 mg and 8 mg doses. The graph presents mean baseline and mean change values indicating improved maximum flow rate and reduced symptom score with increasing Doxazosin doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.